Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. Personal stories

Personal stories

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

What you need to know about Johnson & Johnson’s fourth-quarter and full-year 2025 earnings report

Check out this infographic breakdown of the company’s full-year performance, with highlights from its Innovative Medicine and MedTech businesses.

What is cardiac ablation?

Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.

What is a rheumatic disease?

More than 200 conditions are classified as rheumatic diseases, and they tend to affect the joints and connective tissues. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.

Using your own cells to fight cancer

Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson has treated more than 10,000 patients and counting with this cutting-edge therapy.

What are biologics?

Biologics, a class of medications derived from living organisms, treat a range of conditions including immune-mediated diseases and cancer. Learn how Johnson & Johnson is innovating in biologics to improve treatment options for people around the world.

Care in action: Empowering community health workers to address TB underdiagnosis

J&J CareCommunity is empowering communities to address one of the most significant barriers to ending tuberculosis (TB): underdiagnosis.

Measuring what matters: The evolving role of impact measurement and management

Samatha Curtis from The Good Economy shares four recommendations for impact investors.

J&J Impact Ventures invests in Rology to expand access to critical, high-quality radiology diagnostics

By advancing innovative teleradiology solutions, more patients receive the critical imaging interpretations they need—when and where they need them most.